ProCE Banner Activity

Extended Carfilzomib, Lenalidomide, Dexamethasone + ASCT Effective in Newly Diagnosed MM

Slideset Download
Conference Coverage
Phase II study evaluating induction regimen of KRd, followed by ASCT, KRd consolidation, and maintenance in newly diagnosed multiple myeloma.

Released: June 05, 2015

Expiration: June 03, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

AstraZeneca

Bayer Healthcare Pharma

Bristol Myers Squibb

Celgene

Genentech BioOncology

Incyte

Novartis Pharmaceuticals Corporation